In the era of precision medicine, rapid translation of basic scientific discoveries to patient management has become increasingly crucial to clinical practice, particularly modern oncology. Through tissue analysis, and in collaboration with various clinical specialties, pathologists are at a unique position to interact with both basic scientists and clinical investigators to facilitate timely and efficient translation of major scientific findings to disease prevention, diagnosis, treatment and prognostication.
Armed with state-of-the-art technology, Yale Pathology has various translational subspecialty programs involving active collaborations with basic scientists and clinicians within and outside of the department. Pathology residents and subspecialty fellows are also an integral part of these academic endeavors and are encouraged to make their own contributions to translational research as part of their clinical training experience.
Translational Research Labs
focuses on defining novel predictive biomarkers to identify responders and non-responders among patients who are being treated with immunotherapy for lung cancer.